Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-25-000042
Filing Date
2025-05-13
Accepted
2025-05-13 18:51:34
Documents
1
Period of Report
2025-05-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 10049
  Complete submission text file 0001765581-25-000042.txt   11591
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address
Mulligan Seamus (Reporting) CIK: 0001536639 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 25942030